Clinical Trial Update: The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the effect of semaglutide on disordered eating behavior in patients with type 2 diabetes and overweight status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disordered Eating Behaviors
• Overweight
• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: University Hospital Sestre Milosrdnice | Conditions: Type 2 Diabetes, Overweight | Phase 4 | Status: UNKNOWN